| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.041 | 0.8 |